SUZHOU, China and ROCKVILLE, Md., July 21, 2021 /PRNewswire/ — Ascentage Pharma (6855.HK), a globally focused biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced…
